Catalyst Pharmaceutical CPRX Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 86%-0.2pp | 85.2%-0.8pp | 85.7%-0.6pp | 85.8%-0.9pp | 86.1%-0.6pp | |
| Operating margin | 44.8%+1.6pp | 43.8%+4.1pp | 44.8%+7.0pp | 43.6%+23.8pp | 43.3%+24.2pp | |
| Net margin | 37.1%+0.2pp | 36.4%+3.1pp | 37.6%+6.6pp | 37.4%+21.7pp | 36.9%+21.1pp | |
| Returns | ||||||
| Return on equity | 24.5%-4.6pp | 25.5%-3.9pp | 27.5%-0.8pp | 28.5%+14.6pp | 29.1%+14.6pp | |
| Return on invested capital | 83.9%+8.9pp | 84.5%+21.2pp | 86.6%+28.5pp | 84.4%+55.7pp | 75%+48.3pp | |
| Efficiency | ||||||
| Asset turnover | 0.6×-0.1× | 0.6×-0.1× | 0.6×-0.1× | 0.7×-0.1× | 0.7×-0.1× | |
| Liquidity | ||||||
| Current ratio | 7.1×+1.0× | 6.1×+0.9× | 6.6×+1.5× | 6.7×+1.6× | 6.1×+1.1× | |
| Leverage | ||||||
| Debt-to-equity | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | 0×0.0× | |
| Net debt / EBITDA | -2.5×-0.3× | -2.4×-0.2× | -2.3×-0.2× | -2.3×+0.7× | -2.1×+0.5× | |
| Per Share | ||||||
| Book value per share | $7.98+27.6% | $7.50+28.8% | $7.24+37.4% | $6.71+37.5% | $6.26+37.5% | |
| Valuation | ||||||
| Market capitalization | $3.02B+2.7% | $2.87B+15.2% | $2.41B+2.2% | $2.69B+47.1% | $2.95B+56.8% | |
| Price / earnings | 13.7×-1.3× | 13.4×-1.8× | 11.1×-5.4× | 12.9×-13.9× | 14.9×-13.9× | |
| Price / sales | 5.1×-0.4× | 4.9×-0.2× | 4.2×-1.0× | 4.8×+0.6× | 5.5×+0.9× | |
| Price / book | 3×-0.7× | 3×-0.4× | 2.6×-0.9× | 3.1×+0.1× | 3.7×+0.4× | |
| EV / EBITDA | 7.4×-1.4× | 7.3×-1.2× | 5.8×-3.3× | 7.3×-4.6× | 8.8×-5.0× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Catalyst Pharmaceutical's profit margins?
- Catalyst Pharmaceutical (CPRX) runs a 86.0% gross margin and a 44.8% operating margin, with a 37.1% net margin.
- Where do Catalyst Pharmaceutical's ratios come from?
- Every ratio is computed from Catalyst Pharmaceutical's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
